A Snapshot of Influenza Surveillance, Vaccine Recommendations, and Vaccine Access, Drivers, and Barriers in Selected Middle Eastern and North African Countries
Journal Title: Oman Medical Journal - Year 2018, Vol 33, Issue 4
Abstract
Objectives: Influenza is a vaccine-preventable acute respiratory viral infection that causes epidemics annually around the globe. A regional influenza stakeholder network (MENA-ISN) comprised of experts assessed the status of influenza prevention and control using a structured survey. Methods: A survey questionnaire was used to obtain information from each participating country on surveillance system, the burden of disease, influenza vaccination programs, recommendations, funding and access for vaccine and vaccination, target rate, coverage rate monitoring, and drivers and barriers to influenza vaccination. Results: Out of the 10 countries that participated, nine had an influenza surveillance system and vaccination policy, and seven had World Health Organization (WHO) accredited reference laboratory. Three countries had burden of disease data available and eight had a reimbursement vaccine policy. Influenza vaccine was available in five countries through the Ministry of Health whereas in others, pharmacies also dispensed for the private sector. In all countries, prescribers were physicians, and vaccinators, which could be physicians, nurses, and pharmacists. Eight countries had a set vaccination target rate and only three monitored the influenza coverage rates. Drivers and barriers of vaccination were similar in all countries. Conclusions: Despite existing policies, influenza vaccination coverage remains far below the WHO recommendations. Increased awareness and effective implementation of policies with collaboration of stakeholders can help increase the rates to reach WHO targets.
Authors and Affiliations
Salah Al Awaidy, Abdulhakim Althaqafi, Ghassan Dbaibo
Keywords
Related Articles
- EP ID EP331749
- DOI 10.5001/omj.2018.54
- Views 67
- Downloads 0
New Treatments on the Horizon for Familial Hypercholesterolemia
amilial hypercholesterolemia (FH) is a common genetic disorder with an estimated prevalence of heterozygous FH (HeFH) between 1 in 200–500 and homozygous FH (HoFH) between 1 in 160 000–300 000. FH can be diagnosed using...
Unilateral Facial Weakness
A69-year old woman who was on treatment for pulmonary tuberculosis presented with sudden onset of right-sided facial weakness of 12 hours duration. This was associated with a three-week history of throbbing right ear pai...
Letter in Reply: Important Points in Toxic Epidermal Necrolysis Management
There was a delay in referring the patient to the dermatology team, which was out of our hands, as the medical team saw the patient first and suspected dengue fever since the patient had been traveling and was of South A...
Inborn Errors of Metabolism in Children with Unexplained Developmental Delay in Misan, Iraq
Objectives: We sought to determine the prevalence of inborn errors of metabolism (IEM) in children with unexplained developmental delay and their types. Methods: We conducted a cross-sectional study in Misan, Iraq, over...
Pallister-Killian Mosaic Syndrome in an Omani Newborn: A Case Report and Literature Review
Pallister-Killian mosaic syndrome (PKS) is a rare sporadic condition with multiple congenital anomalies and intellectual deficits caused by mosaic tissue-limited tetrasomy of the short arm of chromosome 12 (12p). The cli...